U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
166141166141FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedHas ResultsRecurrent Adult Diffuse Large Cell Lymphoma|Recurrent Mantle Cell LymphomaDrug: romidepsinhttps://ClinicalTrials.gov/show/NCT00383565
166142166142Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)CompletedHas ResultsAsthmaDrug: Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID|Drug: Mometasone Furoate MDI (MF MDI)|Drug: Formoterol Fumarate 10 mcg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00383552
166143166143Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in AdultsCompletedNo Results AvailableOrthomyxoviridae Infection|Influenza|Myxovirus InfectionBiological: Inactivated Split-virion influenza vaccine|Biological: Inactivated Split-virion influenza vaccine|Biological: Inactivated Split-virion influenza vaccine|Biological: Inactivated Split-virion influenza vaccinehttps://ClinicalTrials.gov/show/NCT00383539
166144166144Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the ElderlyCompletedNo Results AvailableOrthomyxoviridae Infection|Influenza|Myxovirus InfectionBiological: Inactivated, split-virion influenza vaccine|Biological: Inactivated, split-virion influenza vaccinehttps://ClinicalTrials.gov/show/NCT00383526
166145166145Study of Epratuzumab in Systemic Lupus ErythematosusCompletedNo Results AvailableSystemic Lupus ErythematosusBiological: Epratuzumabhttps://ClinicalTrials.gov/show/NCT00383513
166146166146Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk StatusRecruitingNo Results AvailableLymphedema|Breast CancerDevice: Flexitouchhttps://ClinicalTrials.gov/show/NCT00383500
166147166147A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate CancerTerminatedNo Results AvailableProstatic Neoplasms|Prostate CancerDrug: Calcitriol|Drug: Naproxen-n-butyl nitratehttps://ClinicalTrials.gov/show/NCT00383487
166148166148Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast PhaseCompletedNo Results AvailableAdult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Megakaryoblastic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid LeuDrug: Bortezomib|Other: Laboratory Biomarker Analysis|Drug: Tipifarnibhttps://ClinicalTrials.gov/show/NCT00383474
166149166149Computer-Based Stop Smoking Program in Assisting Doctors in Helping Adults Stop SmokingCompletedNo Results AvailableTobacco Use DisorderBehavioral: smoking cessation intervention|Other: counseling interventionhttps://ClinicalTrials.gov/show/NCT00383461
166150166150HSCT for High Risk Inherited Inborn ErrorsCompletedNo Results AvailableAdrenoleukodystrophy|Metachromatic Leukodystrophy|Globoid Cell Leukodystrophy|Tay Sachs Disease|Sandhoffs Disease|Wolman Disease|I-Cell Disease|Sanfilippo Syndrome|GM1 GangliosidosisDrug: Clofarabine|Procedure: Total body Irradiation|Drug: Melphalan|Biological: Hematopoietic Stem Cell Transplantation|Drug: Alemtuzumab|Drug: mycophenylate mofetil|Device: Cyclosporine A|Drug: Hydroxyureahttps://ClinicalTrials.gov/show/NCT00383448
166151166151Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)CompletedHas ResultsChronic Obstructive Pulmonary Disease (COPD)Drug: Mometasone furoate/formoterol (MF/F) combination|Drug: Mometasone furoate/formoterol (MF/F) combination|Drug: Mometasone furoate MDI (MF MDI)|Drug: Formoterol MDI|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00383435
166152166152Study Comparing Arzoxifene With Raloxifene in Women After Menopause With OsteoporosisCompletedNo Results AvailableOsteoporosis, PostmenopausalDrug: Arzoxifene|Drug: Raloxifenehttps://ClinicalTrials.gov/show/NCT00383422
166153166153Multivitamins do Not Improve Radiation Therapy Related FatigueCompletedNo Results AvailableBreast CancerDrug: multivitamins|Drug: placebohttps://ClinicalTrials.gov/show/NCT00383409
166154166154Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to PterygiaCompletedNo Results AvailablePterygiaDrug: Topical Cyclosporinehttps://ClinicalTrials.gov/show/NCT00383396
166155166155Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNo Results AvailableHepatitis BBiological: Hepatitis B adjuvanted vaccine|Biological: Engerix-Bhttps://ClinicalTrials.gov/show/NCT00383383
166156166156Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMDCompletedNo Results AvailableNeovascular Age Related Macular DegenerationDrug: VEGF Trap|Biological: VEGF Traphttps://ClinicalTrials.gov/show/NCT00383370
166157166157Sleepiness and the Risk of FallingCompletedNo Results AvailableAging|Balance|SleepDrug: zolpidemhttps://ClinicalTrials.gov/show/NCT00383357
166158166158Use of FDG PET/CT to Evaluate Crohn DiseaseRecruitingNo Results AvailableCrohn DiseaseProcedure: FDG PET/CThttps://ClinicalTrials.gov/show/NCT00383344
166159166159Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung CancerTerminatedHas ResultsNon-Small-Cell Lung CancerDrug: Pemetrexed|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00383331
166160166160Demographic, Metabolic, and Genomic Description of Neonates With Severe HyperbilirubinemiaCompletedNo Results AvailableHyperbilirubinemia|JaundiceProcedure: Gene mutation samplehttps://ClinicalTrials.gov/show/NCT00383318
166161166161CoolCap Trial, Treatment of Perinatal Hypoxic-Ischemic EncephalopathyCompletedNo Results AvailableNeonatal Hypoxic-Ischemic Encephalopathy (HIE)Device: Cool-Caphttps://ClinicalTrials.gov/show/NCT00383305
166162166162A Study of LY573636 in Treating Patients With Malignant MelanomaCompletedNo Results AvailableMetastatic MelanomaDrug: LY573636https://ClinicalTrials.gov/show/NCT00383292
166163166163Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian CancerCompletedNo Results AvailableCervical Cancer|Ovarian Cancer|SarcomaOther: counseling intervention|Other: study of socioeconomic and demographic variableshttps://ClinicalTrials.gov/show/NCT00383279
166164166164A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal CancerTerminatedNo Results AvailableEsophageal NeoplasmsDrug: Pemetrexed|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00383266
166165166165Methods Study to Characterize Early Indicators of Weight Loss in PeopleCompletedNo Results AvailableObesityBehavioral: caloric restriction - 10%|Behavioral: caloric restriction - 25%|Behavioral: caloric restriction - 50%|Behavioral: caloric restriction - Controlhttps://ClinicalTrials.gov/show/NCT00383253
166166166166Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)CompletedHas ResultsAsthmaDrug: mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID|Drug: Mometasone furoate MDI (MF MDI) 200 mcg|Drug: formoterol fumarate 10 mcg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00383240
166167166167Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNo Results AvailableHepatitis BBiological: Hepatitis B adjuvanted vaccinehttps://ClinicalTrials.gov/show/NCT00383227
166168166168Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)TerminatedNo Results AvailableSystemic Lupus ErythematosusDrug: Epratuzumab|Other: Placebohttps://ClinicalTrials.gov/show/NCT00383214
166169166169Effect of Multi-Purpose Solutions on Ex-Vivo Wetting AnglesCompletedNo Results AvailableContact Lens CareDevice: OptiFree Multi-Purpose Disinfecting Solutionhttps://ClinicalTrials.gov/show/NCT00383201
166170166170An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid ArthritisCompletedNo Results AvailableArthritis, RheumatoidDrug: placebo|Drug: PH-797804|Drug: PH-797804|Drug: PH-797804|Drug: PH-797804https://ClinicalTrials.gov/show/NCT00383188

* Görseller ve İçerik tekif hakkına sahip olabilir